-
cds.ahrq.gov/sites/default/files/reports/CDS_Connect_Pain_Management_Environmental_Scan.pdf
December 01, 2017 - This leads to subsequent considerations and the
likelihood that an order set implementation would be
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
January 01, 2019 - experience using shared, publicly available CDS expressions to
spur attendee discussion and generate considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
April 01, 2021 - WG members provided guidance on translation of the recommendation
statement, raised considerations to … WG members provided guidance
on translation of the recommendation statement, raised considerations to
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
September 01, 2022 - WG members provided guidance on translation of the recommendation
statement, raised considerations to … WG members provided guidance on translation of the
recommendation statement, raised considerations to
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - Using Electronic Health Records and Clinical Decision Support to Provide Guidance on
Occupational Factors which Impact Diabetes: A Final Knowledge Resource Report
Revised and resubmitted December 4, 2015
The Diabetes subject matter expert (SME) group
Convened by the Association of Occupational and Environmenta…
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2020_508.pdf
January 01, 2020 - factors (FAIR, health IT
standards, other repositories, and stakeholders), however, revealed other considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - Medications Adjuvant Analgesic Medications Risk Factors Pain Assessments Historical Treatment Risk Considerations … are the historical treatments that are used and where in Epic they are documented Below are the risk considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - Medications Adjuvant Analgesic Medications Risk Factors Pain Assessments Historical Treatment Risk Considerations … are the historical treatments that are used and where in Epic they are documented Below are the risk considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - The Patient Notification and Intervention Considerations section of the
implementation guide that accompanies
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - Considerations for future lab value specifications include:
- INR > 1.2 OR elevated PTT to represent
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - continuation of each therapy, or combinations of therapies, and weigh this in the context of other considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - continuation of each therapy,
or combinations of therapies, and weigh this in the context of other considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - .
· Review the “clinical considerations” section of this document (including the cited decision log)
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - continuation of each therapy,
or combinations of therapies, and weigh this in the context of other considerations
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
April 01, 2021 - as true for Population 2, then display the
following notification: “Evaluate comorbidities, safety considerations